JNJ vs SOLV
By Alex · Tickerpine
Johnson & Johnson vs Solventum Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | SOLV |
|---|---|---|
| Price | $263.81 | $85.41 |
| Market cap | $635.07B | $14.54B |
| P/E ratio | 40.0 | 10.5 |
| ROE | 20.02% | 33.96% |
| Profit margin | 16.20% | 17.26% |
| Revenue growth | 5.90% | 2.20% |
| Dividend yield | 2.03% | 0.00% |
| Beta | 0.21 | 0.70 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs SOLV in plain English
- JNJ is the bigger company — about 43.7× the market cap of SOLV.
- SOLV is cheaper on earnings (P/E 10.5 vs 40.0).
- SOLV earns a higher return on equity (34% vs 20%).
- JNJ is growing revenue faster (6% vs 2%).
- JNJ pays a dividend (2.03%) while the other effectively doesn't.
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
SOLV return calculator
See what $1,000 in Solventum Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.